PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-03-21

Date Title Company
21-Mar-2024 Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference AccessWire
21-Mar-2024 Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 AccessWire
21-Mar-2024 Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results AccessWire
21-Mar-2024 Anti-Decubitus Dynamic Mattresses market Analysis, Size, Share, Growth, Trends Forecasts 2023-2030 Metastat Insight and Technologies Pvt. Ltd.,
21-Mar-2024 Accuryn Medical Announces Maclean Health FSS Contract Award AccessWire
21-Mar-2024 MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023 MediClin AG
21-Mar-2024 Notice to Attend The Annual General Meeting in XVIVO Perfusion AB (PUBL) AccessWire
21-Mar-2024 ABB’s new SDe Series to boost plant reliability and efficiency with seamless automation system upgrade ABB
21-Mar-2024 EVERSANA Named AI Excellence Award Winner for Third Consecutive Year, Recognized in Company Category for 2024 EVERSANA
21-Mar-2024 OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial OKYO Pharma
21-Mar-2024 Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors Eisbach
21-Mar-2024 Novartis expands its biopharmaceutical manufacturing site in Singapore Novartis
21-Mar-2024 Curve Therapeutics April 2024 Conference Attendance Curve Therapeutics
21-Mar-2024 Mission Therapeutics commences landmark trial of MTX325, a potential disease-modifying treatment for Parkinson’s Disease Mission Therapeutics
21-Mar-2024 The dermatology initiative that could reduce NHS wait lists University of East Anglia
21-Mar-2024 Cambridge Cognition announces formation of new Scientific Advisory Board Cambridge Cognition
21-Mar-2024 Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines Angelini Ventures
21-Mar-2024 STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR STRATEC SE
21-Mar-2024 Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform AccessWire
21-Mar-2024 Innovative Breakthrough in Pain Management: Texas' First Sacroiliac Joint Fusion Performed by Dr. Moustafa Ahmed at CLS Health AccessWire